MARK MCGRATH: Open Payments
NPI 1659870178 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 11 payments from 7 companies in 2025. Trend: 2023 $264 · 2024 $183 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Indivior Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, FANAPT, Auvelity, SUBLOCADE, AUSTEDO XR.
Industry payments across MT — which companies pay providers there.
